Skip to main content
. 2017 Aug 22;2017:1018796. doi: 10.1155/2017/1018796

Table 2.

Biochemical profile of the subject according presence of insulin resistance.

Variables Total (n = 181) Non-IR group (n = 64) IR group (n = 117) p
TC (mmol/L) 5.38 (1.01) 5.43 (0.91) 5.35 (1.06) 0.591
HDL-C (mmol/L) 0.98 (0.28) 1.09 (0.26) 0.93 (0.28) 0.001
LDL-C (mmol/L) 3.67 (0.91) 3.72 (0.80) 3.62 (1.04) 0.495
TAG (mmol/L) 1.37 (1.03; 1.99) 1.15 (0.97; 1.50) 1.52 (1.14; 2.16) <0.001
Glucose (mmol/L) 5.33 (8; 5.7) 5.1 (4.8; 5.3) 5.4 (5.1; 5.8) <0.001
Insulin (μU/mL) 17.0 (7.0) 12.0 (3.0) 20.0 (7.0) <0.001
HOMA-IR 4.2 (1.9) 2.8 (0.7) 5.0 (2.0) <0.001
TAG/HDL-C 1.5 (1.0; 2.3) 1.9 (0.8; 1.5) 1.6 (1.2; 2.6) <0.001
Non-HDL-C (mmol/L) 4.42 (0.95) 4.38 (0.91) 4.42 (0.98) 0.686
APO AI (g/L) 1.33 (0.27) 1.42 (0.24) 1.29 (0.28) 0.001
APO B (g/L) 1.05 (0.23) 1.04 (0.23) 1.05 (0.23) 0.752
LDL size (Å) 270.0 (267.0; 272.0) 271.0 (269.0; 272.0) 270.0 (265.0; 272.0) 0.045
Phenotype A (n, %) 125.0 (69.0) 53.0 (83.0) 72.0 (62.0) 0.003

Data presented as mean (standard deviation) and median (p25-p75). Comparative analysis was performed by Student's t-tests or Mann–Whitney U test (p < 0.05). TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TAG: triacylglycerol; TAG/HDL-C: ratio between TAG and HDL-C; APO AI: apolipoprotein AI; APO B: apolipoprotein B; non-IR group: individuals without insulin resistance; IR group: individuals with insulin resistance.